During cultivation of the Epstein-Barr virus (EBV)-positive Burkitt's lymphoma (BL) line Akata, it was noted that EBV DNA is lost from some of the cells. Isolation of EBV-positive and EBV-negative clones with the same origin made it possible to examine the effects of EBV in BL cells. The results indicate that malignant phenotypes of BL, such as growth in low serum, anchorage-independent growth in soft agar, and tumorigenicity in nude mice, are dependent on the presence of EBV genomes and underline the oncogenic function of EBV in human cancer.
During cultivation of the Epstein-Barr virus (EBV)-positive Burkitt's lymphoma (BL) line Akata, it was noted that EBV DNA is lost from some of the cells. Isolation of EBV-positive and EBV-negative clones with the same origin made it possible to examine the effects of EBV in BL cells. The results indicate that malignant phenotypes of BL, such as growth in low serum, anchorage-independent growth in soft agar, and tumorigenicity in nude mice, are dependent on the presence of EBV genomes and underline the oncogenic function of EBV in human cancer.
Epstein-Barr virus (EBV), a human herpesvirus, is associated with more than 90% of Burkitt's lymphoma (BL) in the African regions of endemicity and less frequently (15 to 20%) with the sporadic BL occurring worldwide. The most consistent finding in BL, whether EBV-infected or not, is a chromosome translocation involving immunoglobulin (Ig) and myc genes. The translocation results in deregulation of c-myc expression and is regarded as the important step in the genesis of BL (2, 11) . On the other hand, the role of EBV is still obscure. EBV infects primary B lymphocytes in vitro and transforms them into blasts that can proliferate indefinitely. Such EBV-transformed lymphoblastoid cells maintain the entire viral genome mostly in a plasmid form and express a limited number of virus-encoded proteins, including six nuclear antigens (EBNA1, EBNA2, EBNA3A, EBNA3B, EBNA3C, and EBNALP) and three membrane proteins (LMP1, LMP2A, and LMP2B), which must play roles in initiation and maintenance of transformation (7) . However, in BL cells there is repression of the latent genes, except EBNA1 (17) . These observations indicate that the functions of EBV that are required for transformation of primary lymphocytes are not necessary in the maintenance and propagation of BL cells, although these functions may be important during BL genesis. It is not known whether EBV contributes to the growth of the EBV-carrying BL that only expresses EBNA1.
The Akata cell line is derived from an EBV-positive BL from a Japanese patient, has a BL-type chromosome translocation, t (8;14) , and expresses surface Ig of the G(K) class (21) . The Akata line is now commonly used to study reactivation of latent EBV because of its rapid and efficient response to cross-linking of cell surface Ig, using antibody to Ig (anti-Ig) (20, 23) . The Akata line retains the tumor phenotype, which is characterized by selective expression of EBNA1, in vitro (17 ' Ten thousand cells were seeded in 3 ml of medium containing 0.33% agarose over 3 ml of medium containing 0.66% agarose in a 60-mm petri dish. After 3 weeks, colonies that contained >100 cells were counted. The results are means + standard errors of four dishes.
C Nude BALB/c mice were injected subcutaneously with 2 x 107 cells per site.
Animals were observed up to 8 weeks for tumors. 1 2 3 4 5 6 7 8 9 10 11 (Table 1) . Both clones grew well in medium with 10% FCS and reached the maximum cell density at around 2 x 106 cells per ml. In 0.1% FCS, EBV-positive clones grew at a slightly reduced rate and at 4 days reached the maximum cell density of around 1.3 x 106 cells per ml, while there was no growth of EBV-negative clones ( Fig. 2A) . Anchorage dependence of cell growth was assayed in 0.33% agarose (SeaPlaque; FMC). In EBV-positive clones, 1 to 1.7% of the cells grew to visible colonies. In contrast, in EBV-negative clones no colony was macroscopically visible (Fig. 2B ). These growth differences between EBV-positive and EBV-negative clones in low serum and soft agarose have been stably retained over 6 months of passages in culture. We further assayed tumorigenicity of EBV-positive and EBVnegative clones in nude mice. Of four EBV-positive clones, three produced tumors at the site of inoculation. By 4 weeks, the tumors ranged in size from 0.7 to 2 cm. Tumor cells consisted of EBNA1-positive cells and were negative for EBNA2 and LMPI (Fig. 2C) . On the other hand, EBVnegative clones were not tumorigenic in nude mice. These results indicate that malignant phenotypes of EBV-carrying BL, such as growth in low serum, anchorage-independent growth in soft agar, and tumorigenicity in nude mice, are dependent on the presence of EBV genomes and underline the oncogenic function of EBV in human cancer.
EBNA1 plays an integral role in the replication of viral plasmids in EBV-infected cells (24, 25) . EBNA1 binds to specific sequences within the plasmid origin of replication (oriP), localized in the BamHI C fragment of EBV DNA (5, 14) . It also regulates the expression of the EBV latent genes (15, 19 (3, 9) . This process has permitted the analysis of biologic roles of EBV in clonal cell populations. However, in EBV-negative BL cells, EBV infection, like infection of primary B lymphocytes, invariably results in expression of a full set of latent genes (12) . There has been no infection system such as that which produces BL-type gene expression, which is characterized by selective expression of EBNA1. The EBV-positive and EBV-negative Akata cell clones, for the first time, make it possible to study the phenotypic and biochemical roles of EBV in BL cells. This is the first report of loss of EBV DNA from BL cells. Studies of why EBV plasmid DNA is not maintained in some Akata cells are currently being carried out.
